Roche Holding AG (XSWX:ROP) FFO


XSWX:ROP Roche Holding AG XSWX:ROP
79 GF Score
Price CHF332.00
GF Value CHF264.69
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Roche Holding AG FFO?

FFO (Funds from operations) only applies to REITs.

XSWX:ROP
79GF Score
Roche Holding AG XSWX:ROP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (XSWX:ROP) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of CHF332.00 is trading 25.4% above its estimated GF Value™ of CHF264.69. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for XSWX:ROP:

  • FFO:
  • GF Value™: CHF264.69 vs. price of CHF332.00 (25.4% above fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ROP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
79GF Score

Get the complete analysis for XSWX:ROP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF332.00
Price
CHF264.69
GF Value